Neuromuscular Blocker Use in Critically Ill Children: Assessing Mortality Risk by Propensity Score–Weighted Analysis. Issue 3 (March 2022)

• Record Type: Journal Article
• Authors: Daverio, Marco; Sperotto, Francesca; Stefani, Chiara; Mondardini, Maria Cristina; Tessari, Anna; Biban, Paolo; Izzo, Francesca; Montani, Cinzia; Lapi, Maria; Picconi, Enzo; Racca, Fabrizio; Marinosci, Geremia Zito; Savron, Fabio; Wolfler, Andrea; Amigoni, Angela
• Is Part Of: Critical care medicine. Volume 50:Issue 3(2022)
• Publication Date: 2022-03
• Subjects: mortality -- neuromuscular blocking agents -- paralysis -- pediatric intensive care unit -- propensity score -- risk factors; Critical care medicine -- Periodicals; Soins intensifs -- Périodiques; 616.028
• DOI: 10.1097/CCM.0000000000005334
• Languages: English
• ISSNs: 0090-3493

Abstract

Abstract : OBJECTIVES: We aim to describe the use of continuous infusion of neuromuscular blocking agents in mechanically ventilated critically ill children and to test its association with in-hospital mortality. DESIGN: Multicenter, registry-based, observational, two-cohort-comparison retrospective study using prospectively collected data from a web-based national registry. SETTING: Seventeen PICUs in Italy. PATIENTS: We included children less than 18 years who received mechanical ventilation and a neuromuscular blocking agent infusion from January 2010 to October 2017. A propensity score–weighted Cox regression analysis was used to assess the relationship between the use of neuromuscular blocking agents and in-hospital mortality. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of the 23, 227 patients admitted to the PICUs during the study period, 3, 823 patients were included. Patients who received a continuous infusion of neuromuscular blocking agent were more likely to be younger ( p < 0.001), ex-premature ( p < 0.001), and presenting with less chronic respiratory insufficiency requiring home mechanical ventilation ( p < 0.001). Reasons for mechanical ventilation significantly differed between patients who received a continuous infusion of neuromuscular blocking agent and patients who did not receive a continuous infusion of neuromuscular blocking agent, with a higher frequency of respiratory and cardiac diagnosis among patients who received neuromuscular blocking agents compared with other diagnoses (all p < 0.001). The covariates were well balanced in the propensity-weighted cohort. The mortality rate significantly differed among the two cohorts (patients who received a continuous infusion of neuromuscular blocking agent 21% vs patients who did not receive a continuous infusion of neuromuscular blocking agent 11%; p < 0.001 by weighted logistic regression). Patients who received a continuous infusion of neuromuscular blocking agent experienced longer mechanical ventilation and PICU stay (both p < 0.001 by weighted logistic regression). A weighted Cox regression analysis found the use of neuromuscular blocking agents to be a significant predictor of in-hospital mortality both in the unadjusted analysis (hazard ratio, 1.7; 95% CI, 1.3–2.2) and in the adjusted one (hazard ratio, 1.6; 95% CI, 1.2–2.1). CONCLUSIONS: Thirteen percent of mechanically ventilated children in PICUs received neuromuscular blocking agents. When adjusting for selection bias with a propensity score approach, the use of neuromuscular blocking agent was found to be a significant predictor of in-hospital mortality.